Temporary Interruption of Baricitinib: Characterization of Interruptions and Effect on Clinical Outcomes in Patients With Rheumatoid Arthritis
Arth Res Ther 2020;22:115 doi.org/10.1186/s13075-020-02199-8
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Arth Res Ther 2020;22:115 doi.org/10.1186/s13075-020-02199-8
Lancet Rheumatol 2020;2:e347–57
RMD Open 2020;6:e001095
Ann Rheum Dis. 2020 Jan 22. pii: annrheumdis-2019-216655.
Please click the links below to go to the CSF review of each paper
Lancet. 2019 Jun 8;393(10188):2303-2311
Mod Rheumatol. 2019 Feb 20:1-23. DOI: 10.1080/14397595.2019.1583711
Ann Rheum Dis. 2019 Feb;78(2):171-178. DOI 10.1136/annrheumdis-2018-213271
Rheumatol Ther. 2018 Dec;5(2):341-353. doi: 10.1007/s40744-018-0113-7
Rheumatology (Oxford) 2018 May; 57(5):900-908